Healthcare utilization and costs in chronic cough

References

• Irwin RS, Madison JM. The diagnosis and treatment of cough. N Engl J Med. 2000;343(23):1715–1721.
   PubMed Web of Science ®Google Scholar
• Morice AH, Jakes AD, Faruqi S, et al. Worldwide survey of chronic cough: a manifestation of enhanced somatosensory response. Eur Respir J. 2014;44(5):1149–1155.
   PubMed Web of Science ®Google Scholar
• Morice AH, Millqvist E, Bieksiene K, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020;55(1):1901136.
   PubMed Web of Science ®Google Scholar
• Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat. 2011;169:1–38.
   Google Scholar
• McGarvey L, Carton C, Gamble LA, et al. Prevalence of psychomorbidity among patients with chronic cough. Cough. 2006;2(1):4.
   PubMedGoogle Scholar
• French CL, Irwin RS, Curley FJ, et al. Impact of chronic cough on quality of life. Arch Intern Med. 1998;158(15):1657–1661.
   PubMedGoogle Scholar
• Dicpinigaitis PV, Tso R, Banauch G. Prevalence of depressive symptoms among patients with chronic cough. Chest. 2006;130(6):1839–1843.
   PubMed Web of Science ®Google Scholar
• Smith JA, Kitt MM, Morice AH, et al. Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial. Lancet Respir Med. 2020;25:1–11.
   Google Scholar
• Chamberlain Mitchell S, Garrod R, Clark L, et al. Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial. Thorax. 2017;72(2):129–136.
   PubMed Web of Science ®Google Scholar
• Morice AH, McGarvey L, Pavord I. Recommendations for the management of cough in adults. Thorax. 2006;61(suppl_1):i1–i24.
   PubMed Web of Science ®Google Scholar
• Rayner L, Matcham F, Hutton J, et al. Embedding integrated mental health assessment and management in general hospital settings: feasibility, acceptability and the prevalence of common mental disorder. Gen Hosp Psychiatry. 2014;36(3):318–324.
   PubMed Web of Science ®Google Scholar
• Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–1736.
   PubMed Web of Science ®Google Scholar
• Devlin NJ, Shah KK, Feng Y, et al. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ. 2018;27(1):7–22.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams J. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613.
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Kroenke K, Williams J, et al. A brief measure for assessing generalized anxiety disorder. Arch Intern Med. 2006;166(10):1092–1097.
   PubMed Web of Science ®Google Scholar
• Herdman D, Sharma H, Simpson A, et al. Integrating mental and physical health assessment in a neuro-otology clinic: feasibility, acceptability, associations and prevalence of common mental health disorders. Clin Med. 2020;20(1):61–66.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams J. The patient health questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284–1292.
   PubMed Web of Science ®Google Scholar
• Morice AH, Fontana GA, Belvisi MG, et al. ERS guidelines on the assessment of cough. Eur Respir J. 2007;29(6):1256–1276.
   PubMed Web of Science ®Google Scholar
• Birring SS, Prudon B, Carr AJ, et al. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003;58(4):339–343.
   PubMed Web of Science ®Google Scholar
• Birring SS, Fleming T, Matos S, et al. The Leicester Cough Monitor: preliminary validation of an automated cough detection system in chronic cough. Eur Respir J. 2008;31(5):1013–1018.
   PubMed Web of Science ®Google Scholar
• Barber J, Thompson S. Multiple regression of cost data: use of generalised linear models. J Health Serv Res Policy. 2004;9(4):197–204.
   PubMedGoogle Scholar
• Dbouk N, Arguedas MR, Sheikh A. Assessment of the PHQ-9 as a screening tool for depression in patients with chronic hepatitis C. Dig Dis Sci. 2008;53(4):1100–1106.
   PubMed Web of Science ®Google Scholar
• Matcham F, Rayner L, Steer S, et al. The prevalence of depression in rheumatoid arthritis: a systematic review and Meta-analysis. Rheumatol. 2013;52:2136–2148.
   PubMed Web of Science ®Google Scholar
• Bakker IM, Terluin B, Van Marwijk H, et al. Test-retest reliability of the PRIME-MD: limitations in diagnosing mental disorders in primary care. Eur. J. Public Health. 2009;19(3):303–307.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Depression in adults with a chronic physical health problem: treatment and management. London: NIHCE; 2009.
   Google Scholar
• Cornford CS. Why patients consult when they cough: a comparison of consulting and non-consulting patients. Br J Gen Pract. 1998;48(436):1751–1754.
   PubMed Web of Science ®Google Scholar
• French CT, Irwin RS, Fletcher KE, et al. Evaluation of a cough-specific quality-of-life questionnaire. Chest. 2002;121(4):1123–1131.
   PubMed Web of Science ®Google Scholar
• Polley L, Yaman N, Heaney L, et al. Impact of cough across different chronic respiratory diseases. Chest. 2008;134(2):295–302.
   PubMed Web of Science ®Google Scholar
• Birring SS, Wijsenbeek MS, Agrawal S, et al. A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial. Lancet Respir Med. 2017;5(10):806–815.
   PubMed Web of Science ®Google Scholar
• Sichali JM, Khan J, Gama EM, et al. Direct costs of illness of patients with chronic cough in rural Malawi-Experiences from Dowa and Ntchisi districts. PLoS One. 2019;14(12):e0225712–12.
   PubMed Web of Science ®Google Scholar
• Kerkhof M, Tran TN, Soriano JB, et al. Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population. Thorax. 2018;73(2):116–124.
   PubMed Web of Science ®Google Scholar
• Chevreul K, Berg Brigham K, Michel M, et al. Costs and health-related quality of life of patients with cystic fibrosis and their carers in France. J Cyst Fibros. 2015;14(3):384–391.
   PubMed Web of Science ®Google Scholar
• Nolan CM, Longworth L, Lord J, et al. The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference. Thorax. 2016;71(6):493–500.
   PubMed Web of Science ®Google Scholar